Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Author:

Bachert Claus,Han Joseph K,Desrosiers Martin,Hellings Peter W,Amin Nikhil,Lee Stella E,Mullol Joaquim,Greos Leon S,Bosso John V,Laidlaw Tanya M,Cervin Anders U,Maspero Jorge F,Hopkins Claire,Olze Heidi,Canonica G Walter,Paggiaro Pierluigi,Cho Seong H,Fokkens Wytske J,Fujieda Shigeharu,Zhang Mei,Lu Xin,Fan Chunpeng,Draikiwicz Steven,Kamat Siddhesh A,Khan Asif,Pirozzi Gianluca,Patel Naimish,Graham Neil M H,Ruddy Marcella,Staudinger Heribert,Weinreich David,Stahl Neil,Yancopoulos George D,Mannent Leda P

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists;Fokkens;Rhinol Suppl,2012

2. International consensus statement on allergy and rhinology: rhinosinusitis;Orlandi;Int Forum Allergy Rhinol,2016

3. Nasal polyps in asthma and rhinitis. A review of 6,037 patients;Settipane;J Allergy Clin Immunol,1977

4. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study;Hedman;Int J Epidemiol,1999

5. The prevalence of olfactory dysfunction in chronic rhinosinusitis;Kohli;Laryngoscope,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3